67 professor-computer "https:" "https:" "https:" "https:" "https:" "Brunel University London" research jobs at Technical University of Denmark
Sort by
Refine Your Search
-
the relevant union. The starting date is 1 May 2026. The position is a full-time position. The position is part of DTU’s Tenure Track program. Read more about the program and the recruitment process here . You
-
including employment history, list of publications indicating scientific highlights, H-index and ORCID (see http://orcid.org/ ) Teaching portfolio including documentation of teaching experience Academic
-
. Further information Further information may be obtained from Prof. Ivan Mijakovic: ivmi@biosustain.dtu.dk You can read more about the hiring department at https://www.biosustain.dtu.dk/ If you are
-
information may be obtained from Daniel Olesen, danole@space.dtu.dk or Michael Schultz Rasmussen, msr@space.dtu.dk You can read more about the division at https://www.space.dtu.dk/english/research
-
, https://ibis.dtu.dk ) and contribute to building a world-class research hub focused on advancing microbial solutions for a sustainable future. DTU Bioengineering is excited to announce a 4-year
-
Engineering & Structural Biology at https://www.biosustain.dtu.dk/research/research-areas/natural-products/enzyme-engineering-and-structural-biology If you are applying from abroad, you may find useful
-
obtained from Senior Researcher Bjarke Eltard Larsen , https://orbit.dtu.dk/en/persons/bjarke-eltard-larsen . You can read more about Department of Civil and Mechanical Engineering at www.construct.dtu.dk
-
materials, catalysis and/or surface science. For Topic 4, candidates must have documented skills within computational modelling of atomistic processes. Experience in scientific programming, e.g. using Python
-
by the Danish EUDP project “RePower-HPC.” Future AI and high-performance computing (HPC) systems demand unprecedented power levels driven by massive data processing. A key challenge is enabling
-
Job Description Migraine affects more than 15% of the global population and remains inadequately treated despite advances in biologics and receptor-targeting therapies. Emerging computational